1. Home
  2. EVAX vs IXHL Comparison

EVAX vs IXHL Comparison

Compare EVAX & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EVAX

Evaxion Biotech

HOLD

Current Price

$5.85

Market Cap

42.7M

Sector

Health Care

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.43

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVAX
IXHL
Founded
2008
2001
Country
Denmark
Australia
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.7M
49.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EVAX
IXHL
Price
$5.85
$0.43
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.33
N/A
AVG Volume (30 Days)
98.3K
25.1M
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,650,000.00
$12,000.00
Revenue This Year
$128.77
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
132.17
N/A
52 Week Low
$1.20
$0.08
52 Week High
$12.15
$2.25

Technical Indicators

Market Signals
Indicator
EVAX
IXHL
Relative Strength Index (RSI) 52.12 56.30
Support Level $5.72 $0.37
Resistance Level $6.70 $0.44
Average True Range (ATR) 0.47 0.04
MACD 0.03 0.00
Stochastic Oscillator 50.26 55.01

Price Performance

Historical Comparison
EVAX
IXHL

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: